Journal of the American Academy of Child & Adolescent Psychiatry
Volume 36, Issue 3, March 1997, Pages 384-389
ARTICLESPredicting Desipramine Levels in Children and Adolescents: A Naturalistic Clinical Study
REFERENCES (22)
- et al.
A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy
J Am Acad Child Adolesc Psychiatry
(1989) - et al.
A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: II. Serum drug levels and cardiovascular findings
J Am Acad Child Adolesc Psychiatry
(1989) - et al.
Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder
J Am Acad Child Psychiatry
(1979) - et al.
EKG effects of imipramine treatment in children
J Am Acad Child Psychiatry
(1978) - et al.
Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine
J Am Acad Child Adolesc Psychiatry
(1992) - et al.
A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents
J Am Acad Child Adolesc Psychiatry
(1993) - et al.
Individual differences in the pharmacokinetics of monomethylated tricyclic antidepressants: role of genetic and environmental factors and clinical importance
Ann N Y Acad Sci
(1971) Drugs and the treatment of psychiatric disorders: antimanic and antidepressant agents
Psychopharmacology in children and adolescents
Sudden death in children treated with a tricyclic antidepressant: a commentary
J Am Acad Child Adolesc Psychiatry
(1991)
Child and adolescent nortriptyline single dose pharmacokinetic parameters: Final report
J Clin Psychopharmacol
(1987)
Cited by (0)
View full text
Copyright © 1997 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.